ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

PAUL AVADANIAN DO

136 A&B LAKE STREET LAKE STREET FAMILY PRACTICE

Ephrata | Pennsylvania | 17522

(717) 721-7718

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,157Medicare Part D Prescriptions Filled, Including Refills

Rank: 334 out of 3734

$727K Total Retail Price of All Prescriptions

Rank: 288 out of 3734

594 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 594 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 594 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 9,634 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 602 489 1 1
LEVOTHYROXINE SODIUM 431 362 2 2
LISINOPRIL 400 336 3 3
AMLODIPINE BESYLATE 363 320 4 5
METFORMIN HCL 334 300 5 8
HYDROCHLOROTHIAZIDE 270 226 6 9
OMEPRAZOLE 268 188 7 4
METFORMIN HCL ER 265 217 8 66
HYDROCODONE-ACETAMINOPHEN 239 122 S3 9 12
GLIMEPIRIDE 229 188 10 37
METOPROLOL SUCCINATE 229 184 10 14
METOPROLOL TARTRATE 226 206 12 6
FUROSEMIDE 205 168 13 7
ATENOLOL 185 162 14 13
ZOLPIDEM TARTRATE 185 99 14 24
CRESTOR 176 166 16 28
ATORVASTATIN CALCIUM 171 142 17 11
CARVEDILOL 169 141 18 30
JANUVIA 148 141 19 50
LOSARTAN-HYDROCHLOROTHIAZIDE 145 137 20 71
WARFARIN SODIUM 131 130 21 10
CYMBALTA 126 51 22 67
SERTRALINE HCL 124 97 23 18
TRAMADOL HCL 123 83 24 20
FLUOXETINE HCL 120 99 25 61
CLOPIDOGREL 120 91 25 23
TAMSULOSIN HCL 119 106 27 29
ALENDRONATE SODIUM 115 109 28 26
CITALOPRAM HBR 105 75 29 16
LOSARTAN POTASSIUM 104 96 30 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 98 86 31 27
POTASSIUM CHLORIDE 98 92 31 19
AMITRIPTYLINE HCL 92 67 R 33 94
PANTOPRAZOLE SODIUM 89 66 34 22
TRAZODONE HCL 85 29 35 49
PLAVIX 82 65 36 39
DIOVAN 80 75 37 31
GABAPENTIN 80 56 37 17
AMLODIPINE BESYLATE-BENAZEPRIL 79 67 39 56
GLIPIZIDE XL 78 65 40 85
DONEPEZIL HCL 77 77 41 25
ACTONEL 76 65 42 188
ESCITALOPRAM OXALATE 75 40 43 68
ALLOPURINOL 74 62 44 33
RAMIPRIL 73 73 45 91
PAROXETINE HCL 72 67 46 59
LIPITOR 72 72 46 90
RANITIDINE HCL 69 51 48 32
AZITHROMYCIN 68 48 49 38
NAMENDA 65 65 50 44
MIRTAZAPINE 63 57 51 45
PRAVASTATIN SODIUM 62 51 52 15
ZETIA 57 39 53 55
ENALAPRIL MALEATE 55 43 54 63
LANTUS SOLOSTAR 53 35 55 102
AMOXICILLIN 52 40 56 108
NOVOLOG FLEXPEN 52 29 56 218
OXYCODONE HCL 52 0 S2 56 58
DILTIAZEM 24HR CD 52 41 56 97
VENLAFAXINE HCL ER 51 25 60 84
ISOSORBIDE MONONITRATE ER 51 47 60 34
DICLOFENAC SODIUM 51 19 60 127
DIOVAN HCT 51 51 60 72
BENICAR 51 51 60 107
SPIRIVA 50 48 65 40
VYTORIN 50 50 65 163
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.